ArticleBioengineering (Basel, Switzerland)2025
Transfer Learning Approach with Features Block Selection via Genetic Algorithm for High-Imbalance and Multi-Label Classification of HPA Confocal Microscopy Images.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advances in deep learning are impressive in various fields and have achieved performance beyond human capabilities in tasks such as image classification, as demonstrated in competitions such as the ImageNet Large Scale Visual Recognition Challenge. Nonetheless, complex applications like medical imaging continue to present significant challenges; a prime example is the Human Protein Atlas (HPA) dataset, which is computationally challenging and complex due to the high-class imbalance with the presence of rare patterns and the need for multi-label classification. It includes 28 distinct patterns and more than 500 unique label combinations, with protein localization that can appear in different cellular regions such as the nucleus, the cytoplasm, and the nuclear membrane. Moreover, the dataset provides four distinct channels for each sample, adding to its complexity, with green representing the target protein, red indicating microtubules, blue showing the nucleus, and yellow depicting the endoplasmic reticulum. We propose a two-phase transfer learning approach based on feature-block extraction from twelve ImageNet-pretrained CNNs. In the first phase, we address single-label multiclass classification using CNNs as feature extractors combined with SVM classifiers on a subset of the HPA dataset. We demonstrate that the simple concatenation of feature blocks extracted from different CNNs improves performance. Furthermore, we apply a genetic algorithm to select the sub-optimal combination of feature blocks. In the second phase, based on the results of the previous stage, we apply two simple multi-label classification strategies and compare their performance with four classifiers. Our method integrates image-level and cell-level analysis. At the image level, we assess the discriminative contribution of individual and combined channels, showing that the green channel is the strongest individually but benefits from combinations with red and yellow. At the cellular level, we extract features from the nucleus and nuclear-membrane ring, an analysis not previously explored in the HPA literature, which proves effective for recognizing rare patterns. Combining these perspectives enhances the detection of rare classes, achieving an F1 score of 0.8 for "Rods & Rings", outperforming existing approaches. Accurate identification of rare patterns is essential for biological and clinical applications, underscoring the significance of our contribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.